{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:35:13Z","timestamp":1793061313851,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xcrm.2026.102928","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:32:07Z","timestamp":1784730727000},"page":"102928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Lei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deze","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ledu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-9727","authenticated-orcid":false,"given":"Guangtong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102928_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","article-title":"Beyond immune checkpoint blockade: emerging immunological strategies","volume":"20","author":"Kubli","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102928_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2026.102928_bib3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102928_bib4","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41591-023-02497-z","article-title":"First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b\/2 trial","volume":"29","author":"Thibaudin","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102928_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102928_bib6","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1158\/0008-5472.CAN-21-1547","article-title":"A Dual PI3K\/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy","volume":"81","author":"Fan","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102928_bib7","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102928_bib8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ccell.2025.05.008","article-title":"When essential metal elements become culprits-Cuproptosis in focus","volume":"43","author":"Hu","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102928_bib9","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ccell.2025.03.031","article-title":"Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance","volume":"43","author":"Lei","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102928_bib10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41418-024-01341-2","article-title":"Dysregulated Wnt\/beta-catenin signaling confers resistance to cuproptosis in cancer cells","volume":"31","author":"Liu","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2026.102928_bib11","doi-asserted-by":"crossref","unstructured":"FDA Expands Indication for Nilotinib. (2018). Cancer Discov. 8, OF11. https:\/\/doi.org\/10.1158\/2159-8290.CD-NB2018-045.","DOI":"10.1158\/2159-8290.CD-NB2018-045"},{"key":"10.1016\/j.xcrm.2026.102928_bib12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/leu.2011.231","article-title":"Release of intracellular calcium primes chronic myeloid leukaemia cells for tyrosine kinase inhibitor-induced apoptosis","volume":"26","author":"Forchap","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2026.102928_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302002","article-title":"Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13-Mediated Stabilization of Bcl-XL","volume":"10","author":"Yan","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102928_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.14336\/AD.2020.0910","article-title":"Nilotinib Improves Bioenergetic Profiling in Brain Astroglia in the 3xTg Mouse Model of Alzheimer's Disease","volume":"12","author":"Adlimoghaddam","year":"2021","journal-title":"Aging Dis."},{"key":"10.1016\/j.xcrm.2026.102928_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","article-title":"The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer","volume":"10","author":"Guo","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xcrm.2026.102928_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00008390-199806000-00011","article-title":"Serum zinc levels are increased in melanoma patients","volume":"8","author":"Ros-Bull\u00f3n","year":"1998","journal-title":"Melanoma Res."},{"key":"10.1016\/j.xcrm.2026.102928_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2023.127370","article-title":"Serum copper status of patients with colorectal cancer: A systematic review and meta-analysis","volume":"82","author":"Squitti","year":"2024","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.xcrm.2026.102928_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54469-7","article-title":"Regulating copper homeostasis of tumor cells to promote cuproptosis for enhancing breast cancer immunotherapy","volume":"15","author":"Guan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102928_bib19","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1158\/0008-5472.CAN-24-2558","article-title":"Targeting ATP7A-Dependent Copper Metabolic Homeostasis Induces Cuproptosis and Suppresses the Progression of Mutant KRAS-Driven Lung Cancer","volume":"85","author":"Zhao","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102928_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13046-022-02475-2","article-title":"HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102928_bib21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","article-title":"Hypoxia inducible factor-1alpha drives cancer resistance to cuproptosis","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102928_bib22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","article-title":"Hypoxia inducible factor-1\u03b1 drives cancer resistance to cuproptosis","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102928_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","article-title":"The MAPK signalling pathways and colorectal cancer","volume":"6","author":"Fang","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102928_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009805","article-title":"Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma","volume":"12","author":"Zhou","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102928_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/2159-8290.CD-17-1119","article-title":"First-in-Class ERK1\/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study","volume":"8","author":"Sullivan","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102928_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2019.01.039","article-title":"Targeting ERK1\/2 protein-serine\/threonine kinases in human cancers","volume":"142","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2026.102928_bib27","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","article-title":"Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102928_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13046-024-02974-4","article-title":"Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade","volume":"43","author":"Zhang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102928_bib29","article-title":"Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity","volume":"4","author":"Liu","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102928_bib30","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1038\/s41467-024-51275-z","article-title":"Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death","volume":"15","author":"Virard","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102928_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.356","article-title":"Braf(V600E) cooperates with Pten loss to induce metastatic melanoma","volume":"41","author":"Dankort","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2026.102928_bib32","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ccell.2022.08.016","article-title":"Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses","volume":"40","author":"Mandula","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102928_bib33","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1038\/s41467-023-39571-6","article-title":"Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102928_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-018-0780-6","article-title":"Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy","volume":"17","author":"Soverini","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2026.102928_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/shem.2003.50034","article-title":"Molecular mechanisms of transformation by the BCR-ABL oncogene","volume":"40","author":"Sattler","year":"2003","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.xcrm.2026.102928_bib36","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/blood-2013-12-545640","article-title":"JAK2\/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo","volume":"124","author":"Gallipoli","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102928_bib37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2010.11.035","article-title":"Inhibition of PDGF, TGF-beta, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib","volume":"55","author":"Liu","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102928_bib38","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jhep.2012.05.012","article-title":"Nilotinib protects the murine liver from ischemia\/reperfusion injury","volume":"57","author":"Ocuin","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102928_bib39","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1038\/s41467-020-19075-3","article-title":"Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1\/2-mediated reactivation of MEK\/ERK\/MYC signaling","volume":"11","author":"Tripathi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102928_bib40","first-page":"335","article-title":"Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia","volume":"140","author":"Tracy","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102928_bib41","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","article-title":"Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion","volume":"80","author":"Voli","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102928_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/17512433.2021.1894129","article-title":"Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies","volume":"14","author":"Wang","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102928_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.684","article-title":"Ubiquitin-specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1\/PTEN\/PI3K signaling","volume":"5","author":"Sun","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.xcrm.2026.102928_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"Weisberg","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102928_bib45","first-page":"1213","article-title":"Pharmacokinetics of CuDIPS in mice","volume":"9","author":"Crispens","year":"1989","journal-title":"Anticancer Res."},{"key":"10.1016\/j.xcrm.2026.102928_bib46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cell.2023.11.037","article-title":"A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma","volume":"187","author":"Pozniak","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102928_bib47","doi-asserted-by":"crossref","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","article-title":"The Encyclopedia of DNA elements (ENCODE): data portal update","volume":"46","author":"Davis","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102928_bib48","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2026.102928_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2026.102928_bib50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","article-title":"MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells","volume":"40","author":"Limagne","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102928_bib51","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102928_bib52","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:25:45Z","timestamp":1793060745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126003459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666379126003459"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102928","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102928"}}